New Mexico Educational Retirement Board reduced its stake in shares of C.R. Bard, Inc. (NYSE:BCR) by 6.9% during the second quarter, Holdings Channel reports. The firm owned 6,774 shares of the medical instruments supplier’s stock after selling 500 shares during the period. New Mexico Educational Retirement Board’s holdings in C.R. Bard were worth $2,172,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Cribstone Capital Management LLC acquired a new position in shares of C.R. Bard during the first quarter valued at about $130,000. Whittier Trust Co. raised its position in shares of C.R. Bard by 7.7% in the first quarter. Whittier Trust Co. now owns 591 shares of the medical instruments supplier’s stock valued at $147,000 after buying an additional 42 shares during the period. ClariVest Asset Management LLC acquired a new position in shares of C.R. Bard during the first quarter valued at about $148,000. SRS Capital Advisors Inc. raised its position in shares of C.R. Bard by 0.7% in the first quarter. SRS Capital Advisors Inc. now owns 598 shares of the medical instruments supplier’s stock valued at $148,000 after buying an additional 4 shares during the period. Finally, Parallel Advisors LLC raised its position in shares of C.R. Bard by 283.8% in the first quarter. Parallel Advisors LLC now owns 499 shares of the medical instruments supplier’s stock valued at $153,000 after buying an additional 369 shares during the period. 85.32% of the stock is currently owned by institutional investors.

C.R. Bard, Inc. (NYSE:BCR) opened at 319.13 on Friday. C.R. Bard, Inc. has a 1-year low of $203.63 and a 1-year high of $323.27. The company’s 50-day moving average is $318.89 and its 200 day moving average is $282.81. The company has a market cap of $23.19 billion, a price-to-earnings ratio of 41.90 and a beta of 0.59.

C.R. Bard (NYSE:BCR) last announced its earnings results on Thursday, July 27th. The medical instruments supplier reported $2.92 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.84 by $0.08. C.R. Bard had a return on equity of 48.70% and a net margin of 14.99%. The business had revenue of $979.70 million for the quarter, compared to analysts’ expectations of $976.53 million. During the same period in the prior year, the business posted $2.54 earnings per share. The firm’s revenue was up 5.2% on a year-over-year basis. On average, equities analysts predict that C.R. Bard, Inc. will post $11.84 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Friday, August 4th. Investors of record on Monday, July 24th were issued a $0.26 dividend. This represents a $1.04 annualized dividend and a yield of 0.33%. The ex-dividend date was Thursday, July 20th. C.R. Bard’s payout ratio is presently 13.67%.

ILLEGAL ACTIVITY WARNING: This article was first published by Daily Political and is owned by of Daily Political. If you are reading this article on another website, it was illegally stolen and reposted in violation of international trademark & copyright laws. The legal version of this article can be accessed at https://www.dailypolitical.com/2017/08/11/new-mexico-educational-retirement-board-sells-500-shares-of-c-r-bard-inc-bcr.html.

Several brokerages have recently issued reports on BCR. Cowen and Company raised their target price on shares of C.R. Bard from $240.00 to $317.00 and gave the company a “market perform” rating in a research note on Monday, April 24th. BidaskClub raised shares of C.R. Bard from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 8th. Zacks Investment Research raised shares of C.R. Bard from a “hold” rating to a “buy” rating and set a $351.00 target price on the stock in a research note on Tuesday, June 6th. Jefferies Group LLC raised their target price on shares of C.R. Bard from $237.00 to $317.00 and gave the company a “hold” rating in a research note on Monday, April 24th. Finally, Wells Fargo & Company lowered shares of C.R. Bard from an “outperform” rating to a “market perform” rating in a research note on Tuesday, April 25th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating, one has issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $285.67.

About C.R. Bard

C. R. Bard, Inc (Bard) is engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company operates through the manufacture and sale of medical devices segment. It sells a range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities on a global basis.

Want to see what other hedge funds are holding BCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for C.R. Bard, Inc. (NYSE:BCR).

Institutional Ownership by Quarter for C.R. Bard (NYSE:BCR)

Receive News & Ratings for C.R. Bard Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for C.R. Bard Inc. and related companies with MarketBeat.com's FREE daily email newsletter.